We report a general, practical and scalable hydroacylation reaction of ethylene with aromatic carboxylicacids with the synergistic combination of nickel and photoredox catalysis. Under ambient temperature and pressure, feedstock chemicals such as ethylene can be converted into high-value-added aromatic ketones in moderate to good yields (up to 92%) with reaction time of 2–6 hours.
The present invention provides compounds having formula (I):
and pharmaceutically acceptable derivatives thereof, wherein R
1
-R
4
, n, p, A, B, D, E, L and AR
1
are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of disorders mediated by the CD11/CD18 family of cellular adhesion molecules (e.g., LFA-1).
[EN] BENZOFURAN SALT MORPHIC FORMS AND MIXTURES FOR THE TREATMENT OF MENTAL DISORDERS OR MENTAL ENHANCEMENT<br/>[FR] FORMES POLYMORPHES DE SELS DE BENZOFURANE ET MÉLANGES POUR LE TRAITEMENT DE TROUBLES MENTAUX OU POUR L'AMÉLIORATION MENTALE
申请人:[en]TACTOGEN INC
公开号:WO2023107653A2
公开(公告)日:2023-06-15
Salt morphic forms, morphic salt mixtures, and specified salt mixtures of pharmaceutically active benzofuran compositions are provided for the treatment of mental disorders or for mental enhancement, including for entactogenic therapy. The present invention also includes salt morphic forms, morphic salt mixtures, and specified salt mixtures of benzofuran compounds, compositions thereof, and methods for generally modulating central nervous system activity and treating central nervous system disorders.